Virpax Pharmaceuticals Correlations

VRPX Stock

USD 0.46 0.02 4.17%

The current 90-days correlation between Virpax Pharmaceuticals and Panbela Therapeutics is 0.16 (i.e., Average diversification). The correlation of Virpax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Virpax Pharmaceuticals Correlation With Market

Average diversification

The correlation between Virpax Pharmaceuticals and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virpax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Moving together with Virpax Stock

0.65

INMB

INmune Bio

Pair Corr

Moving against Virpax Stock

0.58	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.58	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.57	EWTX	Edgewise Therapeutics	Pair Corr
0.57	BCTXW	BriaCell Therapeutics	Pair Corr
0.47	WAT	Waters	Pair Corr
0.44	BHC	Bausch Health Companies	Pair Corr
0.43	GANX	Gain Therapeutics	Pair Corr
0.43	GILD	Gilead Sciences	Pair Corr
0.39	EBS	Emergent Biosolutions	Pair Corr
0.38	HCM	HUTCHMED DRC	Pair Corr
0.65	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.59	CVS	CVS Health Corp Sell-off Trend	Pair Corr
0.35	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.31	CTLT	Catalent	Pair Corr

Related Correlations Analysis

	PBLA	REVB	PALI	VRAX	QNRX	ZIVO	RNXT	KTTA	ABIO	NTRB
PBLA		0.39	0.76	0.58	-0.2	0.81	-0.31	0.64	0.25	-0.2	PBLA
REVB	0.39		0.3	0.72	0.23	0.38	-0.28	0.24	0.01	-0.4	REVB
PALI	0.76	0.3		0.33	0.06	0.83	-0.61	0.69	0.16	0.21	PALI
VRAX	0.58	0.72	0.33		0.18	0.33	-0.13	0.16	0.08	-0.6	VRAX
QNRX	-0.2	0.23	0.06	0.18		-0.18	-0.2	-0.33	-0.23	-0.21	QNRX
ZIVO	0.81	0.38	0.83	0.33	-0.18		-0.62	0.78	0.27	0.2	ZIVO
RNXT	-0.31	-0.28	-0.61	-0.13	-0.2	-0.62		-0.54	-0.09	-0.4	RNXT
KTTA	0.64	0.24	0.69	0.16	-0.33	0.78	-0.54		0.26	0.32	KTTA
ABIO	0.25	0.01	0.16	0.08	-0.23	0.27	-0.09	0.26		0.04	ABIO
NTRB	-0.2	-0.4	0.21	-0.6	-0.21	0.2	-0.4	0.32	0.04		NTRB
	PBLA	REVB	PALI	VRAX	QNRX	ZIVO	RNXT	KTTA	ABIO	NTRB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ZIVO	+ 0.83	PALI
ZIVO	+ 0.81	PBLA
KTTA	+ 0.78	ZIVO
PALI	+ 0.76	PBLA
VRAX	+ 0.72	REVB
KTTA	+ 0.69	PALI

High negative correlations

RNXT	- 0.62	ZIVO
RNXT	- 0.61	PALI
NTRB	- 0.6	VRAX
KTTA	- 0.54	RNXT
NTRB	- 0.4	RNXT
NTRB	- 0.4	REVB

Risk-Adjusted Indicators

There is a big difference between Virpax Stock performing well and Virpax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virpax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PBLA	7.11	(2.50)	0.00	(1.32)	0.00	0.00	10.70	(17.30)	88.58
REVB	3.64	(0.67)	0.00	(0.22)	0.00	0.00	8.97	(7.83)	34.52
PALI	3.46	(0.36)	0.00	0.61	0.00	0.00	5.97	(8.55)	24.25
VRAX	5.71	(0.95)	0.00	2.22	0.00	0.00	9.65	(12.90)	61.28
QNRX	5.95	0.39	0.06	0.40	6.53	(8.76)	17.65	(9.68)	74.46
ZIVO	3.01	(0.96)	0.00	(0.27)	0.00	0.00	5.31	(6.67)	36.36
RNXT	3.41	0.41	0.08	0.82	3.89	(4.51)	7.55	(6.20)	40.06
KTTA	5.25	(0.30)	0.00	(0.42)	0.00	0.00	8.27	(11.00)	68.44
ABIO	4.85	(0.91)	0.00	(0.76)	0.00	0.00	6.61	(5.89)	123.58
NTRB	4.66	0.26	0.03	1.37	4.72	(5.80)	11.41	(8.63)	33.94

Virpax Pharmaceuticals Corporate Management

CPA CPA	CFO Sec	Profile
Jeffrey MD	Chief VP	Profile
JD MBA	Chief Officer	Profile
Shana Panzarella	Chief Staff	Profile
Anthony MBA	Chairman CEO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC